National Research Co. (NASDAQ:NRC) Shares Sold by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC lowered its stake in National Research Co. (NASDAQ:NRC) by 14.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 7,912 shares of the company’s stock after selling 1,308 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in National Research were worth $313,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in National Research by 184.3% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,179 shares of the company’s stock worth $126,000 after buying an additional 2,061 shares during the period. Cardinal Capital Management increased its position in shares of National Research by 3.0% during the fourth quarter. Cardinal Capital Management now owns 16,525 shares of the company’s stock worth $656,000 after acquiring an additional 483 shares during the last quarter. Conestoga Capital Advisors LLC lifted its stake in shares of National Research by 1.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 780,806 shares of the company’s stock worth $30,889,000 after acquiring an additional 7,591 shares in the last quarter. Portside Wealth Group LLC boosted its holdings in National Research by 11.9% in the fourth quarter. Portside Wealth Group LLC now owns 5,238 shares of the company’s stock valued at $207,000 after purchasing an additional 555 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new stake in National Research during the 4th quarter valued at approximately $147,000. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, TheStreet lowered National Research from a “b-” rating to a “c+” rating in a research report on Thursday, January 11th.

National Research Trading Down 16.5 %

NASDAQ NRC opened at $29.76 on Thursday. The company has a market capitalization of $709.78 million, a price-to-earnings ratio of 23.81 and a beta of 0.45. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.67 and a quick ratio of 0.67. National Research Co. has a 12 month low of $29.62 and a 12 month high of $47.25. The company’s fifty day moving average price is $37.13 and its two-hundred day moving average price is $39.20.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Tuesday, February 13th. The company reported $0.36 EPS for the quarter. The business had revenue of $38.00 million for the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Friday, March 29th were issued a $0.12 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.61%. National Research’s dividend payout ratio (DPR) is 38.40%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.